Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05MDB
|
||||
| Former ID |
DNC008271
|
||||
| Drug Name |
N,N-dimethyl-2,2,2-triphenylacetamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H21NO
|
||||
| Canonical SMILES |
CN(C)C(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
|
||||
| InChI |
1S/C22H21NO/c1-23(2)21(24)22(18-12-6-3-7-13-18,19-14-8-4-9-15-19)20-16-10-5-11-17-20/h3-17H,1-2H3
|
||||
| InChIKey |
JGBIXOAQARJTNI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Calcium-activated potassium channel | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 2008 Feb 28;51(4):976-82. Epub 2008 Jan 31.Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.